Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Microbiol Biotechnol ; 24(3): 371-8, 2014 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-24346468

RESUMO

The aim of the present study was to investigate the antigenotoxic properties of the probiotic Lactobacillus rhamnosus IMC501; DNA damage was induced by one representative food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mice were treated orally with suspensions of lactobacilli for 10 days before administration of food mutagen. During the treatment, the abundance of lactobacilli in feces, as assessed by qPCR analysis, increased, whereas ß-glucuronidase and N-acetyl-ß-glucosaminidase activities decreased. The extent of DNA damage was measured in colon and liver cells by comet assay. In colonocytes, diet supplementation with IMC501 resulted in a significant inhibition of DNA damage induced by PhIP. The results obtained in this in vitro study suggest that Lactobacillus rhamnosus IMC501 used as a dietary supplement can provide a useful integration of antimutagen food components of the normal diet, which are generally lower than the protective level.


Assuntos
Carcinógenos/antagonistas & inibidores , Carcinógenos/toxicidade , Imidazóis/antagonistas & inibidores , Imidazóis/toxicidade , Lacticaseibacillus rhamnosus/metabolismo , Probióticos/administração & dosagem , Acetilglucosaminidase/análise , Animais , Carga Bacteriana , Carcinógenos/metabolismo , Ensaio Cometa , Suplementos Nutricionais , Células Epiteliais/efeitos dos fármacos , Fezes/enzimologia , Fezes/microbiologia , Glucuronidase/análise , Hepatócitos/efeitos dos fármacos , Imidazóis/metabolismo , Camundongos , Reação em Cadeia da Polimerase em Tempo Real , Resultado do Tratamento
2.
Environ Mol Mutagen ; 49(3): 192-9, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18213654

RESUMO

The present study was designed to investigate the putative antigenotoxic effects of supplementing the diet of rats treated with the colon carcinogen 1,2-dimethylhydrazine hydrochloride (DMH) with a Lactobacillus casei strain using an in vivo approach. The antigenotoxic response was evaluated in colon and liver cells using the alkaline comet assay. Since the balance between the bioactivation and detoxification metabolic pathways is crucial for the formation of toxic and genotoxic metabolites, alterations in the level of some xenobiotic metabolizing enzymes (XME) were studied in liver preparations. In the challenge group (L. casei + DMH), lactobacilli-supplemented diet, there was a decrease in the extent of DMH-induced DNA damage, especially in colon cells. Compared with control rats, there was less basal DNA damage in colon cells of rats fed on a lactobacilli-supplemented diet. These findings are the first to give clear evidence of DNA-protective effects of lactobacilli against basal DNA damage. Moreover, the chemopreventive effects were accompanied by changes in the activities of several XME. The observed decrease in the concentration of nonenzymatic antioxidants (i.e. GSH) and the reduced activity of enzymatic antioxidants (i.e., GST, GPx, and SOD) in liver could reflect an overall reduction in the level of oxidative stress in rats on a diet supplemented with the L. casei suspension compared with control rats (basal state). Thus, the concentrations of GSH and the activities of GST, GPx, and SOD could be downregulated by supplementing the diet with L. casei as a response to an improved antioxidant status.


Assuntos
1,2-Dimetilidrazina/toxicidade , Alquilantes/toxicidade , Carcinógenos/toxicidade , Suplementos Nutricionais , Lacticaseibacillus casei , Mutagênicos/toxicidade , Substâncias Protetoras/farmacologia , Acetilglucosaminidase/metabolismo , Animais , Colo/citologia , Ensaio Cometa , Sistema Enzimático do Citocromo P-450/metabolismo , Dano ao DNA , Fezes/enzimologia , Glucuronidase/metabolismo , Hepatócitos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Microssomos Hepáticos/enzimologia , Ratos , Ratos Sprague-Dawley , beta-Glucosidase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA